- Home
- GNSS vs BNTC Comparison
GNSS vs BNTC Comparison
Compare GNSS & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNSS
- BNTC
- Stock Information
- Founded
- GNSS 1992
- BNTC 1995
- Country
- GNSS United States
- BNTC United States
- Employees
- GNSS N/A
- BNTC N/A
- Industry
- GNSS Consumer Electronics/Appliances
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- GNSS Consumer Staples
- BNTC Health Care
- Exchange
- GNSS Nasdaq
- BNTC Nasdaq
- Market Cap
- GNSS 98.9M
- BNTC 366.6M
- IPO Year
- GNSS N/A
- BNTC N/A
- Fundamental
- Price
- GNSS $1.77
- BNTC $13.17
- Analyst Decision
- GNSS Strong Buy
- BNTC Strong Buy
- Analyst Count
- GNSS 3
- BNTC 6
- Target Price
- GNSS $5.33
- BNTC $23.83
- AVG Volume (30 Days)
- GNSS 117.0K
- BNTC 226.1K
- Earning Date
- GNSS 08-05-2025
- BNTC 05-14-2025
- Dividend Yield
- GNSS N/A
- BNTC N/A
- EPS Growth
- GNSS N/A
- BNTC N/A
- EPS
- GNSS N/A
- BNTC N/A
- Revenue
- GNSS $27,780,000.00
- BNTC N/A
- Revenue This Year
- GNSS $91.14
- BNTC N/A
- Revenue Next Year
- GNSS $75.44
- BNTC N/A
- P/E Ratio
- GNSS N/A
- BNTC N/A
- Revenue Growth
- GNSS N/A
- BNTC N/A
- 52 Week Low
- GNSS $1.46
- BNTC $7.05
- 52 Week High
- GNSS $4.04
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- GNSS 57.13
- BNTC 44.14
- Support Level
- GNSS $1.48
- BNTC $10.91
- Resistance Level
- GNSS $1.85
- BNTC $12.74
- Average True Range (ATR)
- GNSS 0.09
- BNTC 1.37
- MACD
- GNSS 0.04
- BNTC -0.29
- Stochastic Oscillator
- GNSS 79.49
- BNTC 36.51
About GNSS Genasys Inc.
Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.